| Dr Paul Merlis, MD | |
|
743 Spring St Ne, Gainesville, GA 30501-3715 | |
| (770) 536-2146 | |
| (770) 536-7895 |
| Full Name | Dr Paul Merlis |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 743 Spring St Ne, Gainesville, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518933449 | NPI | - | NPPES |
| 93BFDXV | Other | GA | MEDICARE PIN URGENT CARE FRIENDSHIP |
| 000294533C | Medicaid | GA | |
| 000294533D | Medicaid | GA | |
| 000294533E | Other | GA | MEDICAID URGENT CARE FRIENDSHIP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 026339 (Georgia) | Primary |
| Entity Name | Georgia Emergency Department Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508886912 PECOS PAC ID: 5597751032 Enrollment ID: O20040517001016 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have received a $7 million grant from the Bill & Melinda Gates Foundation aimed at eliminating river blindness and elephantiasis, two neglected tropical diseases that annually sicken millions.
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder at the Nicotinic Acetylcholine Receptors as Therapeutic Targets Symposium (nAChR2009) in Lincolnshire, Illinois on October 15, 2009.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human papillomavirus for more than 20 years.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Merlis, MD Po Box 2938, Gainesville, GA 30503-2938 Ph: (770) 536-2146 | Dr Paul Merlis, MD 743 Spring St Ne, Gainesville, GA 30501-3715 Ph: (770) 536-2146 |
News Archive
Researchers at Washington University School of Medicine in St. Louis have received a $7 million grant from the Bill & Melinda Gates Foundation aimed at eliminating river blindness and elephantiasis, two neglected tropical diseases that annually sicken millions.
Eli Lilly and Company announced today that the United States Food and Drug Administration (FDA) has approved Strattera (atomoxetine HCI) for maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. Strattera, a selective norepinephrine reuptake inhibitor, is the first FDA-approved non-stimulant to treat ADHD in children, adolescents and adults.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder at the Nicotinic Acetylcholine Receptors as Therapeutic Targets Symposium (nAChR2009) in Lincolnshire, Illinois on October 15, 2009.
A study published in the August issue of Cancer Research has resulted in several premature and potentially misleading conclusions when it comes to fructose and its effect on pancreatic tumor cells. Unfortunately, the media covering this story, and even the authors, have been too quick to extrapolate the results of laboratory research on pure fructose to real-world conditions, which is not appropriate or helpful to consumers.
The Fifth Annual AACR Team Science Award will be given to a team of internationally renowned molecular biologists, epidemiologists, biostatisticians and clinicians from Fred Hutchinson Cancer Research Center and University of Washington who have worked together on human papillomavirus for more than 20 years.
› Verified 8 days ago
Dr. Keith Edwin Leap Ii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 786-357-9327 | |
Dr. Philippe Gadegbeku, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-536-2146 Fax: 770-536-7895 | |
Dr. George Houlditch, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-536-2146 | |
Heather Holstein, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 | |
Jason Sanghwa Oh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-219-9000 | |
William E Davis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-536-2146 Fax: 770-536-7895 | |
Dr. Gary Kempler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 743 Spring St Ne, Gainesville, GA 30501 Phone: 770-536-2146 Fax: 770-536-7895 |